Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s00262-020-02493-z.pdf
Reference45 articles.
1. Miranti CK, Koul HR (2017) Meeting Report of Joint Society of Basic Urologic Research (SBUR) and European Society of Urological Research (ESUR) symposium fall 2017. Am J Clin Exp Urol 5(1):1–92 (Abstract# P54)
2. National Cancer Institute (2019) Cancer Stat Facts: Prostate Cancer. https://seer.cancer.gov/statfacts/html/prost.html. Accessed Dec 2019
3. Kiessling A, Wehner R, Fussel S, Bachmann M, Wirth MP, Schmitz M (2012) Tumor-associated antigens for specific immunotherapy of prostate cancer. Cancers (Basel) 4:193–217
4. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411–422
5. Higano CS, Schellhammer PF, Small EJ, Burch PA, Nemunaitis J, Yuh L, Provost N, Frohlich MW (2009) Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer 115:3670–3679
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unlocking Immunity: Innovative prostate cancer vaccine strategies;International Immunopharmacology;2024-12
2. Ovine papillomavirus type 3 virus-like particle-based tools for diagnosis and detection of infection;Vaccine;2024-09
3. Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming;International Journal of Molecular Sciences;2023-06-07
4. Current status and progress of the development of prostate cancer vaccines;Journal of Cancer;2023
5. Virus-like Particles for TEM Regulation and Antitumor Therapy;Journal of Functional Biomaterials;2022-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3